Delivery Order SPE2DR25D1002-SPE2DR26FGJ6M
Award Date 11/12/25
Potential Completion Date 12/4/25
Potential Value $1.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,732.55 delivery order to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/mL vials, with an ultimate completion date of August 11, 2025. This firm fixed-price contract represents a non-competitive, non-set-aside delivery order issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is listed as Conshohocken,...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $6,934.96 for HYPERRAB 300 Unit/ML Vial 5ML on October 30, 2025, with completion expected by November 21, 2025. This firm fixed-price delivery order represents a competitive, non-set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. HYPERRAB is a rabies immunoglobulin product used for post-exposure prophylaxis in rabies prevention, supporting the federal...
- The Defense Logistics Agency awarded a $16,632.48 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of HYPERRAB 300 Unit/ML Vial medication. This firm fixed price contract, with an ultimate completion date of August 18, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $13,860.40 by the Defense Logistics Agency (DLA) for the supply of HYPERRAB 300 Unit/ML Vial medication. This firm fixed-price, non-set-aside contract was executed on October 17, 2025, with an ultimate completion date of November 7, 2025. The place of performance is listed as Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,790.80 firm fixed price delivery order to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/ML vial (5ML) on July 25, 2025, with an ultimate completion date of August 15, 2025. This is a non-set-aside contract, competitively awarded to support federal medical procurement needs. The product will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office and primary distribution operations. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,367.52 to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/ML Vial on November 14, 2025, with an ultimate completion date of December 8, 2025. This firm fixed price delivery order is non-set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed at the vendor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $33,547 delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of HYPERRAB 300 units/ml, a rabies immunoglobulin product. The contract is a firm fixed-price delivery order with an ultimate completion date of December 2, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to meet...
- The Defense Logistics Agency awarded a delivery order valued at $3,467.48 to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of HYPERRAB 300 Unit/ML Vial 5ML, a rabies immunoglobulin product. The order, which is a firm fixed price delivery order with no set-aside designation, is scheduled for completion by December 2, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a competitive procurement under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $5,197.65 to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/ML vials, with an ultimate completion date of September 4, 2025. This non-set-aside, competitively awarded contract operates under a firm fixed-price structure and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $5,201.22 to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of HYPERRAB 300 Unit/ML Vial 5ML, a rabies immunoglobulin product. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, scheduled for completion by December 2, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...